Salesforce shares rose 1.30% to $215.05 on February 2, 2026, supported by broader market recovery and strong underlying fundamentals, particularly the performance of its Agentforce AI product.
- The Agentforce AI product generated $540 million in recurring revenue during Q3 fiscal 2026, marking a significant 330% year-over-year increase.
- Wall Street maintains a "Moderate Buy" consensus, setting a median price target of $327.40, implying a substantial 43% upside potential.
- Analysts cite a solid balance sheet ($8.24B net cash) and strategic AI integration as key drivers for potential 2026 recovery.